Doru Georg Margineanu

Author

UCB Pharma (Belgium)

Also Known As

", D MARGINEANU, D.-G. Margineanu, D.G Margineanu, Doru Georg Margineanu, Doru Margineanu

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Belgium)University of Rome Tor Vergata

About

Doru Georg Margineanu is an author at UCB Pharma (Belgium) specializing in medicine, social sciences, and neurophysiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.1K
2	Social Sciences	16	17	1K
3	Neuroscience	16	19	1.1K
4	Neurology	10	10	670
5	Health Sciences	2	2	75

Doru Georg Margineanu

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices Isabelle Niespodziany, Henrik Klitgaard, Doru Georg Margineanu Neuroscience Letters Rat Hippocampal SlicesNeuromodulationNeurophysiologyMedicineNeurotransmitter	2001	216
Levetiracetam does not modulate neuronal voltage-gated Na and T-type Ca currents Cristina Zona, Isabelle Niespodziany, Caterina Marchetti, Seizure	2001	149
Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action? Michael Madeja, Doru Georg Margineanu, Ali Gorji, Neuropharmacology Hyperpolarization (Biology)NeurophysiologyMedicineVoltage-operated Potassium CurrentsNeuromodulation Therapies	2003	146
Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs Doru Georg Margineanu, Henrik Klitgaard Pharmacological Research NeurophysiologyMedicinePsychotropic MedicationNeuronal HypersynchronyNeuropharmacology	2000	126
Brivaracetam (ucb 34714) inhibits Na+ current in rat cortical neurons in culture Cristina Zona, Massimo Pieri, Irene Carunchio, Epilepsy Research Rat Cortical NeuronsMolecular NeuroscienceNeurophysiologyMedicinePhysiology	2009	69
Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neurons Mikael ngehagen, Doru Georg Margineanu, Elinor Ben‐Menachem, Neuroreport New DrugNeurophysiologyMedicineSynaptic TransmissionNeurotransmitter	2003	68
Can gap-junction blockade preferentially inhibit neuronal hypersynchrony vs. excitability? Doru Georg Margineanu, Henrik Klitgaard Neuropharmacology Hyperpolarization (Biology)NeurophysiologyMedicineSynaptic TransmissionNeurology	2001	62
Absence of Negative Impact of Levetiracetam on Cognitive Function and Memory in Normal and Amygdala-Kindled Rats Yves Lamberty, Doru Georg Margineanu, Henrik Klitgaard Epilepsy & Behavior NeuropsychologyNegative ImpactMedicinePsychotropic MedicationAmygdala-kindled Rats	2000	57
Effect of the New Antiepileptic Drug Levetiracetam in an Animal Model of Mania Yves Lamberty, Doru Georg Margineanu, Henrik Klitgaard Epilepsy & Behavior PsychiatryBehavioral NeuroscienceMedicineAnimal ModelPsychopharmacology	2001	49
Desynchronizing effect of levetiracetam on epileptiform responses in rat hippocampal slices Isabelle Niespodziany, Henrik Klitgaard, Doru Georg Margineanu Neuroreport Epileptiform ResponsesSynaptic TransmissionNeurotransmitterAntiepileptic ActionNeurotransmission	2003	45

Page 1